These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10757392)

  • 41. Micrometastases in sentinel lymph nodes: few data make for hard decisions.
    Rowan K
    J Natl Cancer Inst; 2009 Oct; 101(20):1374-6. PubMed ID: 19797724
    [No Abstract]   [Full Text] [Related]  

  • 42. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Axilla scoring systems predicting risk of non-sentinel-node metastasis in breast cancer patients with a positive sentinel node.
    Barranger E; Morel O; Coutant C
    Ann Surg Oncol; 2008 Apr; 15(4):1261-2; author reply 1263-4. PubMed ID: 18259821
    [No Abstract]   [Full Text] [Related]  

  • 44. Sentinel node biopsy.
    Harv Womens Health Watch; 1998 Jun; 5(10):7. PubMed ID: 9663013
    [No Abstract]   [Full Text] [Related]  

  • 45. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN.
    van la Parra RF; Peer PG; Ernst MF; Bosscha K
    Eur J Surg Oncol; 2011 Apr; 37(4):290-9. PubMed ID: 21316185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma probe guided sentinel node biopsy in breast cancer.
    Gulec SA; Moffat FL; Carroll RG; Krag DN
    Q J Nucl Med; 1997 Sep; 41(3):251-61. PubMed ID: 9274133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interest of periareolar injection for colorimetric detection of sentinel node in breast cancer].
    Mignotte H; Treilleux I; Chassagne-Clément C; Bem C; Lopez R; Martin X; Brémond A
    Bull Cancer; 2000 Jul; 87(7-8):600-3. PubMed ID: 10969216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The challenge of sentinel lymph node biopsy.
    Anderson TJ
    Histopathology; 1999 Jul; 35(1):82-4. PubMed ID: 10383718
    [No Abstract]   [Full Text] [Related]  

  • 49. Internal mammary chain sentinel lymph node identification in breast cancer.
    Noguchi M; Tsugawa K; Miwa K
    J Surg Oncol; 2000 Feb; 73(2):75-80. PubMed ID: 10694642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Sentinel node biopsy in breast cancer--a minimally invasive procedure for staging of the axilla].
    Haid A; Fritzsche H; Peschina W; Gruber-Mösenbacher U; Jasarevic S; Hillbrand E; Müller G; Köberle-Wührer R; Schmidle T; Breitfellner G
    Wien Klin Wochenschr; 1999 Mar; 111(6):219-25. PubMed ID: 10234775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and histological factors associated with sentinel node identification in breast cancer.
    Kollias J; Gill PG; Coventry BJ; Malycha P; Chatterton B; Farshid G
    Aust N Z J Surg; 2000 Jul; 70(7):485-9. PubMed ID: 10901574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
    Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
    Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intradermal blue dye to identify sentinel lymph-node in breast cancer.
    Borgstein PJ; Meijer S; Pijpers R
    Lancet; 1997 Jun; 349(9066):1668-9. PubMed ID: 9186389
    [No Abstract]   [Full Text] [Related]  

  • 54. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
    Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
    Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.
    Rehman S; Sardi A; Spiegler E; Colandrea J; Frishberg D
    Md Med J; 1999; 48(3):105-10. PubMed ID: 10394225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
    Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sentinel lymphatic node biopsy for breast cancer in practice].
    Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
    Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings].
    Cserni G; Boross G; Baltás B
    Orv Hetil; 1998 Aug; 139(32):1899-903. PubMed ID: 9731445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sentinel node biopsy: evaluating a new technique.
    Ung OA; Wetzig NR
    Med J Aust; 1999 Nov; 171(9):452-3. PubMed ID: 10615333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.